Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Biohaven Ltd. (BHVN) had Stock-Based Compensation of $53.06M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
-- |
|
$-221.68M |
|
-- |
|
-- |
|
$221.56M |
|
$-221.56M |
|
$0.49M |
|
$-221.07M |
|
$-221.07M |
|
$-221.68M |
|
$-221.68M |
|
$-221.68M |
|
$-221.68M |
|
$-221.56M |
|
$-219.31M |
|
101.94M |
|
101.94M |
|
$-2.17 |
|
$-2.17 |
|
Balance Sheet Financials | |
$382.76M |
|
$17.79M |
|
$76.19M |
|
$458.95M |
|
$164.03M |
|
-- |
|
$35.42M |
|
$199.45M |
|
$259.50M |
|
$239.71M |
|
$259.50M |
|
102.10M |
|
Cash Flow Statement Financials | |
$-165.12M |
|
$164.88M |
|
$0.37M |
|
$102.54M |
|
$102.69M |
|
$0.15M |
|
Stock-Based Compensation |
$53.06M |
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.33 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-165.59M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-85.43% |
|
-92.48% |
|
-48.30% |
|
-85.43% |
|
$2.54 |
|
$-1.62 |
|
$-1.62 |